Bronwyn Le Grice, CEO and Managing Director of ANDHealth said, “Having a strong regulatory environment for digital heath products not only provides access to safe, evidence-based digital health products to improve patient outcomes, but also improves the commercial potential of new innovations."
ANDHealth will deliver a series of interactive webinars, live Q&A and feedback sessions, alongside customised 1-1 coaching on SaMD considerations, through ANDHealth’s Office Hours program.
“A sound understanding of the regulatory environment will support our digital health innovators and entrepreneurs build an internationally competitive digital health sector, including the distinctions between evidence-based digital health products and digital therapeutics and general consumer wellness products,” said Bronwyn.
“We are delighted to partner with the TGA to help Australia’s emerging and innovative digital health companies navigate the regulatory landscape for software-based digital health products. The TGA has played a critical role in helping shape the Government’s current framework through a two-year consultation with industry. From September 2021, we can complement the TGA’s efforts with industry and we applaud the TGA for their ongoing commitment to industry consultation,” said Bronwyn.
Adj Prof. John Skerritt, Deputy Secretary, and head of the TGA said, “The TGA is pleased to be working with ANDHealth to provide these additional channels of communication and education to complement TGA’s existing interactions with the sector. Companies are encouraged to leverage ANDHealth’s expertise and offerings, as well as to continue to contact the TGA directly if desired.”
ANDHealth’s Office Hours program on SaMD are due to begin in September.